Covid: Oxford jab offers less S Africa variant protection
Developers say they are likely to have a modified version of the jab by autumn to combat the variant. …
Andrew Pollard, professor of paediatric infection and immunity and chief investigator on the Oxford vaccine trial, said: “This study confirms that the pandemic coronavirus will find ways to continue to spread in vaccinated populations, as expected, but, taken with the promising results from other studies in South Africa using a similar viral vector, vaccines may continue to ease the toll on health care systems by preventing severe disease.”
About The Author
